prnewswire.comArgo Biopharma Announces First Patient Dosed in Phase 2b Trial of siRNA Therapeutic BW-20829 in Patients with Elevated Lp(a)2 months ago
prnewswire.comGlobal Biopharma Company Triples Research Commitment to Tishman Speyer and Breakthrough Properties' One Milestone at the Harvard Enterprise Research Campus, One of Boston's Most Anticipated New Developments2 months ago
prnewswire.comMandara Biopharma Files IND with the FDA to Advance Dronabinol Oral Solution Formulation for Alzheimer's Agitation3 months ago
prnewswire.comArgo Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference3 months ago
prnewswire.comBiopharma's Innovation Engine Powers Ahead, but Its Business Model Faces Mounting Strain3 months ago
prnewswire.comVi Releases 2026 State of AI Reports, Defining the New Performance Standard for Healthcare, Biopharma, and Wellness3 months ago
prnewswire.comScinai CEO Amir Reichman to Co-Lead Manufacturers Association Biopharma Manufacturing Roundtable at HealthIL3 months ago
CashuRedHill Biopharma Launches Talicia to Combat H. pylori Infections and Enhance Patient Outcomesabout 1 month ago
CashuRedHill Biopharma Launches Talicia to Combat H. pylori: A Key Advancement in Treatmentabout 1 month ago